Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-23-035712

Chair and CEO sold 112,000 shares at an average $24.08 ($2,696,449)

  • Chair and CEO acquired 112,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lewis William · Chair and CEO

Table I: Non-derivative

13 lines
Date Transaction Shares Price Value Owned after D/I
2023-10-27 Exercise or conversion : show line 1 in the form 10b5-1 +53,363 $14.24 $759,889 53,363 I
2023-10-27 Sale : show line 2 in the form 10b5-1 −53,363 $24.04 $1,282,847 0 I
2023-10-27 Exercise or conversion : show line 3 in the form 10b5-1 +1,322 $14.24 $18,825 1,322 I
2023-10-27 Sale : show line 4 in the form 10b5-1 −1,322 $25.08 $33,156 0 I
2023-10-27 Exercise or conversion : show line 5 in the form 10b5-1 +315 $14.24 $4,486 315 I
2023-10-27 Sale : show line 6 in the form 10b5-1 −315 $26.00 $8,190 0 I
2023-10-27 Exercise or conversion : show line 7 in the form 10b5-1 +500 $14.24 $7,120 500 I
2023-10-27 Exercise or conversion : show line 8 in the form 10b5-1 +55,350 $14.24 $788,184 289,274 I
Open-market sales · 112,000 sh · avg $24.08 · $2,696,449

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-10-27 Exercise or conversion : show line 14 in the form 10b5-1 Stock Option (right to buy) −55,000 $14.24 2023-10-31 55,000 500 I
2023-10-27 Exercise or conversion : show line 15 in the form 10b5-1 Stock Option (right to buy) −500 $14.24 2023-10-31 500 0 I
2023-10-27 Exercise or conversion : show line 16 in the form 10b5-1 Stock Option (right to buy) −57,000 $14.24 2023-10-31 57,000 0 I
Loading xslF345X05/wk-form4_1698782649.xml…